4//SEC Filing
Horn Howard 4
Accession 0000950170-25-032750
CIK 0001515673other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:56 PM ET
Size
7.4 KB
Accession
0000950170-25-032750
Insider Transaction Report
Form 4
Horn Howard
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+28,160→ 28,160 totalExercise: $42.92Exp: 2035-03-01→ Common Stock (28,160 underlying) - Award
Common Stock
2025-03-01+15,653→ 107,954 total
Footnotes (3)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001786335
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:56 PM ET
- Size
- 7.4 KB